Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation. In
the last few decades, new insights into RA‐specific autoantibodies and B cells have greatly …

The presence of disease-specific autoantibody responses and the efficacy of B cell-targeting
therapies in rheumatoid arthritis (RA) indicate a pivotal role for B cells in disease …

The immune response to citrullinated antigens is found almost exclusively in patients with
rheumatoid arthritis (RA). It is a dynamic response that expands before the onset of disease …

Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation.
The presence of autoantibodies in the sera of RA patients has provided many clues to the …

The presence of autoantibodies is one of the hallmarks of rheumatoid arthritis (RA). In the
past few decades, rheumatoid factors (autoantibodies that recognize the Fc-tail of …

Autoantibodies represent a hallmark of rheumatoid arthritis (RA), with the rheumatoid factor
(RF) and antibodies against citrullinated proteins (ACPA) being the most acknowledged …

Though its etiology remains unknown thus far, the role that autoimmune processes play in
rheumatoid arthritis (RA) pathogenesis has been widely proven. Given the easier …

Objective Autoantibodies against antigens carrying distinct post-translational modifications
(PTMs), such as citrulline, homocitrulline or acetyllysine, are hallmarks of rheumatoid …

Antibodies targeting citrullinated proteins (ACPAs [anticitrullinated protein antibodies]) are
commonly found in patients with rheumatoid arthritis (RA), strongly associate with distinct …

Rheumatoid arthritis (RA) is an autoimmune/inflammatory disease affecting 0.5 to 1% of
adults worldwide and frequently leads to joint destruction and disability. Early diagnosis and …